Page 165 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 165

Patient preferences in treatment of high-grade CIN
16. Koeneman MM, Kruse AJ, Kooreman LF, Zur Hausen A, Hopman AH, Sep SJ, et al. TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial. BMC cancer. 2016;16(1):132.
17. Choung RS LIG, Schleck CD, Ziegenfuss JY, Beebe TJ, Zinsmeister AR, Talley NJ. A low response rate does not necessarily indicate non-response bias in gastroenterology survey research: a population-based study. J Public Health. 2013(21):87-95.
18. Kyrgiou M, Mitra A, Arbyn M, Stasinou SM, Martin-Hirsch P, Bennett P, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis. Bmj. 2014;349:g6192.
8
 163





























































































   163   164   165   166   167